EUVIMEDEUVIMED entdecken
Crossref

lncRNA Gm20257 alleviates pathological cardiac hypertrophy by modulating the PGC-1α–mitochondrial complex IV axis

Tong Yu, Qiang Gao, Guofang Zhang, Tianyu Li, Xiaoshan Liu, Chao Li, Lan Zheng, Xiang Sun, Jianbo Wu, Huiying Cao, Fangfang Bi, Ruifeng Wang und 5 weitere

Frontiers of Medicine · 2024

DOI: 10.1007/s11684-024-1065-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers of Medicine, 2024. Verfasst von Tong Yu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Research Center for Druggability of Cardiovascular Noncoding RNA, Institute for Frontier Medical Technology, Shanghai Univ…. Hauptthemen laut MEDLINE: Cardiomegaly, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, RNA, Long Noncoding. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomegalyPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaRNA, Long NoncodingAnimalsMaleMiceDisease Models, AnimalMice, Inbred C57BLMyocytes, CardiacHumans

Stichwörter der Autor:innen

ATPPGC-1αcardiac hypertrophylncRNA Gm20257mitochondrial complex IV

Substanzen

Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPpargc1a protein, mouseRNA, Long Noncoding

Autor:innen und Institutionen

  • Shanghai Frontiers Science Research Center for Druggability of Cardiovascular Noncoding RNA, Institute for Frontier Medical Technology, Shanghai University of Engineering Science, Shanghai, 201620, China.
  • Department of Physiology, School of Basic Medicine, Harbin Medical University, Harbin, 150081, China.
  • State Key Laboratory of Frigid Zone Cardiovascular Disease, Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Educa…
  • Department of Physiology, School of Basic Medicine, Harbin Medical University, Harbin, 150081, China. lvlifanggaoqiang@163.com.
  • The Center of Functional Experiment Teaching, School of Basic Medicine, Harbin Medical University, Harbin, 150081, China. lvlifanggaoqiang@163.com.
  • Shanghai Frontiers Science Research Center for Druggability of Cardiovascular Noncoding RNA, Institute for Frontier Medical Technology, Shanghai University of Engineering Science, Shanghai, 201620, China. shanhl@sues.ed…

Zitieren

APA

Yu, T., Gao, Q., Zhang, G., Li, T., Liu, X., Li, C., Zheng, L., Sun, X., Wu, J., Cao, H., Bi, F., Wang, R., Liang, H., Li, X., Zhou, Y., Lv, L., & Shan, H. (2024). lncRNA Gm20257 alleviates pathological cardiac hypertrophy by modulating the PGC-1α–mitochondrial complex IV axis. Frontiers of Medicine. https://doi.org/10.1007/s11684-024-1065-7

Vancouver

Yu T, Gao Q, Zhang G, Li T, Liu X, Li C, et al. lncRNA Gm20257 alleviates pathological cardiac hypertrophy by modulating the PGC-1α–mitochondrial complex IV axis. Frontiers of Medicine. 2024. doi:10.1007/s11684-024-1065-7

BibTeX
@article{Yu2024,
  author = {Yu, Tong and Gao, Qiang and Zhang, Guofang and Li, Tianyu and Liu, Xiaoshan and Li, Chao and Zheng, Lan and Sun, Xiang and Wu, Jianbo and Cao, Huiying and Bi, Fangfang and Wang, Ruifeng and Liang, Haihai and Li, Xuelian and Zhou, Yuhong and Lv, Lifang and Shan, Hongli},
  title = {lncRNA Gm20257 alleviates pathological cardiac hypertrophy by modulating the PGC-1α–mitochondrial complex IV axis},
  journal = {Frontiers of Medicine},
  year = {2024},
  doi = {10.1007/s11684-024-1065-7}
}
Kostenlos starten →